NASDAQ:TELO | Balance Sheet | Telomir Pharmaceuticals, Inc.

Complete source-backed balance-sheet history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$5.37M$5.37M$332,424.00$332,424.00$5.03M
2026-03-31$5.79M$5.79M$827,310.00$827,310.00$4.96M
2025-12-31$7.34M$7.34M$1.43M$1.43M$5.91M
2025-09-30$7.4M$7.4M$422,807.00$422,807.00$6.98M
2025-06-30$754,323.00$829,611.00$829,611.00$348,388.00$348,388.00$481,223.00
2025-03-31$402,999.00$491,188.00$491,188.00$652,294.00$652,294.00-$161,105.00
2024-12-31$1.27M$1.32M$1.32M$680,968.00$680,968.00$643,037.00
2024-09-30$1.04M$1.04M$599,911.00$599,911.00$442,074.00
2024-06-30$2.1M$2.1M$534,155.00$534,155.00$1.63M
2024-03-31$3.5M$3.5M$486,552.00$486,552.00$3.02M
2023-12-31$435,225.00$4.77M$1.34M$1.34M$3.44M
2023-09-30$2.18M
2023-06-30$3.89M
2023-03-31-$510,215.00
2022-12-31$48,730.00$48,730.00$986,008.00$986,008.00-$937,278.00
2021-12-31-$138,131.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.